Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

67.71
Delayed Data
As of Dec 02
 +1.74 / +2.64%
Today’s Change
64.18
Today|||52-Week Range
88.16
-19.64%
Year-to-Date
Why Eli Lilly Shares Lost 8% in November
Dec 03 / MotleyFool.com - Paid Partner Content
Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Mine Field
Nov 30 / TheStreet.com - Paid Partner Content
3 Reasons Why Incyte Corporation Stock Could Soar in 2017
Dec 03 / MotleyFool.com - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content
Biotechs Look Dangerous Again As Trump Rally Fades
Dec 02 / Investing Channel - Paid Partner Content
Plaques, tangles and the mystery of Alzheimer's disease
Nov 29 / FT.com - Paid Partner Content
Quest to cure Alzheimer's disease exhibits symptoms of failure
Nov 30 / FT.com - Paid Partner Content
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
Nov 28 / TheStreet.com - Paid Partner Content
J&J (JNJ) Stands Tall in 2016: Reasons for Outperformance
Nov 30 / Zacks.com - Paid Partner Content
3 Top Drug Stocks for Your Retirement Portfolio
Nov 28 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close65.97
Today’s open66.30
Day’s range65.96 - 68.39
Volume12,272,207
Average volume (3 months)4,670,014
Market cap$74.7B
Dividend yield3.01%
Data as of 4:03pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+2.64%
Earnings growth (next 5 years)+10.90%
Revenue growth (last year)+1.75%
P/E ratio29.4
Price/Sales4.50
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-0.68-0.36%
NVONovo Nordisk+0.38+1.13%
AZNAstraZeneca+0.08+0.31%
ABTAbbott Laboratories+0.30+0.80%
Data as of 4:03pm ET, 12/02/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.97
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts


Search for Jobs